Patent Assignment
Reel/Frame 044956/0395
Patent Security Assignment and Assumption Agreement
Recorded: 2017-12-20
Pages: 27
Assignor
BIOPHARMA SECURED DEBT FUND II HOLDINGS CAYMAN LP
Executed: 2017-12-20
Assignee
CPPIB CREDIT EUROPE S.À R.L.
10-12 BOULEVARD ROOSEVELT, LUXEMBOURG, L-2450, LUXEMBOURG
Covered Properties
(76)
Pharmaceutical Composition Comprising Omega-3 Fatty Acid and Hydroxy-Derivative of a Statin and Methods of Using Same
Application:
12/888,994 →
Publication:
US US20110071176A1
Highly Purified Ethyl Epa and Other Epa Derivatives
Application:
12/951,620 →
Publication:
US US20110065793A1
Compositions and Methods for Treating and/or Preventing Cardiovascular Disease
Application:
13/040,977 →
Publication:
US US20110218243A1
Pharmaceutical Composition Comprising Eicosapentaenoic Acid and Nicotinic Acid and Methods of Using Same
Application:
13/061,865 →
Publication:
US US20110236476A1
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Application:
13/124,628 →
Publication:
US US20120093922A1
Methods of Treating Hypertriglyceridemia
Application:
13/198,221 →
Publication:
US US20110288171A1
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Stable Pharmaceutical Composition and Methods of Using Same
Application:
13/266,374 →
Publication:
US US20120100208A1
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Application:
13/359,114 →
Publication:
US US20130012580A1
Methods of Treating Hypertriglyceridemia
Application:
13/403,694 →
Publication:
US US20120156285A1
Methods of Treating Hypertriglyceridemia
Application:
13/404,666 →
Publication:
US US20120157530A1
Compositions and Methods for Lowering Triglycerides
Application:
13/404,686 →
Publication:
US US20120157531A1
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Application:
13/418,591 →
Publication:
US US20120172432A1
Highly Purified Ethyl Epa and Other Epa Derivatives
Application:
13/439,392 →
Publication:
US US20120195963A1
Methods of Treating Hypertriglyceridemia
Application:
13/482,720 →
Publication:
US US20120237594A1
Methods of Treating Hypertriglyceridemia
Application:
13/671,197 →
Publication:
US US20130131170A1
Pharmaceutical Composition Comprising Eicosapentaenoic Acid and Nicotinic Acid and Methods of Using Same
Methods of Treating Pediatric Metabolic Syndrome
Application:
15/672,603 →
Publication:
US US20180085334A1
Methods of Treating or Preventing Prostate Cancer
Co-Administration of Atorvastatin and Ethyl Eicosapentaenoic Acid or a Derivative Thereof
Application:
15/716,764 →
Publication:
US US20180015071A1
Methods and Systems for Offering Financial Products
Methods of Reducing Triglycerides and Ldl-C
Chimeric Double-Stranded Nucleic Acid
Compositions and Methods for Lowering Levels of High-Sensitivity C-Reactive Protein (Hs-Crp) in a Subject
Pharmaceutical Composition Comprising Eicosapentaenoic Acid and Low Dose Nicotinic and Methods of Using Same
Application:
61/093,506 →
Methods of Treating and/or Preventing Cardiovascular Diseases and Disorders
Application:
61/151,291 →
Methods of Treating Hypertriglyceridemia
Application:
61/173,755 →
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Application:
61/173,759 →
Stable Pharmaceutical Composition and Methods of Using Same
Application:
61/173,763 →
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Application:
61/187,132 →
Pharmaceutical Composition Comprising Omega-3 Fatty Acid and Hydroxy-Derivative of a Statin and Methods of Using Same
Application:
61/245,086 →
Compositions and Methods for Treating and/or Preventing Cardiovascular Disease
Application:
61/310,443 →
Low Eructation Composition and Methods for Treating and/or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
Application:
61/417,691 →
Methods of Treating Hypertriglyceridemia
Application:
61/556,573 →
Compositions and Methods for Lowering Levels of High-Sensitivity (Hs-Crp) in a Subject
Application:
61/584,013 →
Pharmaceutical Composition Comprising Omega-3 Fatty Acid and Hydroxy-Derivative of a Statin and Methods of Using Same
Application:
61/655,879 →
Methods of Treating Hypercholesterolemia
Application:
61/655,890 →
Compositions and Methods for Lowering Levels of High-Sensitivity C-Reactive Protein (Hs-Crp) in a Subject
Application:
61/656,347 →
Methods of Treating Cardiovscular Disease in Statin-Intolerant Subjects
Application:
61/666,428 →
Methods of Reducing Ldl-P
Application:
61/666,433 →
Methods of Treating Pediatric Metabolic Syndrome
Application:
61/666,437 →
Methods of Treating Hypertriglyceridemia
Application:
61/666,442 →
Methods of Reducing the Risk of a Cardiovascular Event in a Subject on Statin Therapy
Application:
61/666,447 →
Methods of Treating Hypertriglyceridemia
Application:
61/670,408 →
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Application:
61/723,108 →
Compositions and Methods for Lowering Triglycerides in a Subject With Renal Insufficiency
Application:
62/508,789 →
Methods of Treating or Preventing Bone Loss
Application:
62/545,796 →
Methods of Reducing or Preventing Oxidation of High Density Lipoprotein (HDL)
Application:
62/545,809 →
Methods of Reducing or Preventing Oxidation of High Density Lipoprotein (HDL)
Application:
62/586,268 →
Therapeutic Combinations of Fatty Acids
Patent:
6,479,544 →
Application:
09/893,473 →
Highly Purified Ethyl Epa and Other Epa Derivatives
Methods of Treating Hypertriglyceridemia
Stable Pharmaceutical Composition and Methods of Using Same
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Compositions and Methods for Lowering Triglycerides
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Compositions and Methods for Lowering Triglycerides in a Subject on Concomitant Statin Therapy
Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Stable Pharmaceutical Composition and Methods of Using Same
Methods of Treating Mixed Dyslipidemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Stable Pharmaceutical Composition and Methods of Using Same
Stable Pharmaceutical Composition and Methods of Using Same
Stable Pharmaceutical Composition and Methods of Using Same
Methods of Treating Hypertriglyceridemia
Stable Pharmaceutical Composition and Methods of Using Same
Stable Pharmaceutical Composition and Methods of Using Same
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 25, 2012
From: PEET, MALCOLM; VADDADI, KRISHNA S.
To: LAXDALE LIMITED
Reel/Frame 028270/0071 →
Change of Name
May 25, 2012
From: LAXDALE LIMITED
To: AMARIN NEUROSCIENCE LIMITED
Reel/Frame 028275/0763 →
Proof of Ownership of Shares
May 25, 2012
From: AMARIN NEUROSCIENCE LIMITED
To: AMARIN CORPORATION PLC
Reel/Frame 028275/0333 →
Assignment of Assignor's Interest
May 30, 2012
From: PEET, MALCOLM; VADDADI, KRISHNA S.
To: LAXDALE LIMITED
Reel/Frame 028291/0162 →
Assignment of Assignor's Interest
May 30, 2012
From: MANKU, MEHAR
To: AMARIN CORPORATION PLC.
Reel/Frame 028291/0058 →
Assignment of Assignor's Interest
May 30, 2012
From: MANKU, MEHAR; OSTERLOH, IAN; WICKER, PIERRE; BRAECKMAN, RENE
To: AMARIN PHARMA, INC.
Reel/Frame 028291/0106 →
Assignment of Assignor's Interest
May 30, 2012
From: MANKU, MEHAR; OSTERLOH, IAN; WICKER, PIERRE; BRAECKMAN, RENE
To: AMARIN PHARMA, INC.
Reel/Frame 028291/0098 →
Assignment of Assignor's Interest
May 30, 2012
From: ROWE, JONATHAN
To: AMARIN PHARMA, INC.
Reel/Frame 028291/0077 →
Assignment of Assignor's Interest
May 30, 2012
From: MANKU, MEHAR; ROWE, JONATHAN
To: AMARIN CORPORATION PLC.
Reel/Frame 028291/0129 →
Change of Name
May 30, 2012
From: LAXDALE LIMITED
To: AMARIN NEUROSCIENCE LIMITED
Reel/Frame 028301/0246 →
Proof of Ownership of Shares
May 30, 2012
From: AMARIN NEUROSCIENCE LIMITED
To: AMARIN CORPORATION PLC
Reel/Frame 028301/0228 →
Assignment of Assignor's Interest
May 31, 2012
From: AMARIN CORPORATION PLC
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 028295/0289 →
Assignment of Assignor's Interest
May 31, 2012
From: AMARIN PHARMA INC.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 028295/0491 →
Assignment of Assignor's Interest
Jun 11, 2012
From: AMARIN CORPORATION PLC
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 028351/0358 →
Security Agreement
Dec 19, 2012
From: AMARIN PHARMACEUTICALS IRELAND LIMITED
To: BIOPHARMA SECURED DEBT FUND II HOLDINGS CAYMAN LP
Reel/Frame 029499/0087 →
Assignment of Assignor's Interest
Aug 5, 2013
From: MANKU, MEHAR; OSTERLOH, IAN; WICKER, PIERRE; BRAECKMAN, RENE
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 030960/0014 →
Assignment of Assignor's Interest
Dec 31, 2013
From: MANKU, MEHAR; OSTERLOH, IAN; WICKER, PIERR; BRAECKMAN, RENE
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 031862/0814 →
Assignment of Assignor's Interest
Jan 2, 2014
From: MANKU, MEHAR
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 031911/0297 →
Assignment of Assignor's Interest
Aug 9, 2017
From: SONI, PARESH
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 043243/0212 →
Assignment of Assignor's Interest
Oct 4, 2017
From: KWIZERA, FELIX B.; MIBUARI, ERIC; OGEGA, VIOLETTE; SPEAKMAN, SKYLER
To: INTERNATIONAL BUSINESS MACHINES CORPORATION
Reel/Frame 043781/0040 →
Security Interest
Dec 21, 2017
From: AMARIN PHARMACEUTICALS IRELAND LIMITED
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044938/0257 →
Assignment of Assignor's Interest
Jan 25, 2018
From: BRAECKMAN, RENE; STIRTAN, WILLIAM; SONI, PARESH
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 045142/0145 →
Assignment of Assignor's Interest
Jan 25, 2018
From: BRAECKMAN, RENE; STIRTAN, WILLIAM; SONI, PARESH
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 045142/0099 →
Assignment of Assignor's Interest
Jan 25, 2018
From: OSTERLOH, IAN; WICKER, PIERRE; BRAECKMAN, RENE; SONI, PARESH
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 044725/0206 →
Assignment of Assignor's Interest
Jan 25, 2018
From: ZAKRZEWSKI, JOSEPH S.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 045142/0694 →